Skip to main content
Show — Main navigation
Hide — Main navigation
Hair & Scalp
Coping During COVID
Expert Insights in Derm
AAD Summer Meeting
SDPA Fall Conference
AAD VMX 2020
GW Advances in Acne
San Diego Dermatology Symposium
Centers of Excellence
Clinical Size Not Predictive of Invasive Lentigo Maligna
In a recent study, researchers investigated whether clinical area could predict invasion of lentigo maligna.
Study Highlights Genetic Susceptibility of HS
A recent study found high heritability among patients with hidradenitis suppurativa (HS), suggesting a stronger than previously assumed genetic basis for this disease.
Risankizumab Improves PsO and Quality of Life
Findings from a recent study found risankizumab improved both moderate to severe psoriasis symptoms and patients’ quality of life.
Ocular Symptoms Are Common Among Patients With AD
Findings from a recent study showed patients with moderate to severe atopic dermatitis had a high burden of ocular surface disorders and related symptoms.
Contact Dermatitis Caused by Personal Care Products Increasing
Personal care product-related contact dermatitis is increasing among both men and women, according to the results of a recent study.
PPAR Agonist Improves Pruritus in Patients With Cholestatic Diseases
Findings from a recent randomized controlled trial showed a broad peroxisome proliferator-activated receptor agonist improved moderate to severe pruritus among patients with primary sclerosing cholangitis and primary biliary cholangitis.
Topical Fusidic Acid Improves PIH Following CO2 Lasers for Acne Scars
A recent randomized controlled trial assessed the efficacy of fusidic acid cream compared with erythromycin ointment as postoperative treatment following ablative fractional CO2 laser for acne scars.
BMI Does Not Affect the Need for Skin Grafting in HS
Findings from a recent study suggested body mass index did not influence the need for a skin graft among patients with hidradenitis suppurativa undergoing excision.
Latent TB Activation Uncommon With Secukinumab Treatment
Findings from a recent study assessed the risk of tuberculosis, latent tuberculosis, and tuberculosis reactivation among patients treated with secukinumab.
Topical Antimicrobial Peptide Improves Dysbiosis in AD
A synthetic indolicidin analogue antimicrobial peptide with activity against Staphylococcus aureus improved dysbiosis but not the clinical signs of atopic dermatitis.
Stay in the know.
The Dermatologist Newsletter
Back to Top